No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Torrent Pharmaceuticals Limited, an Ahmedabad, India-based pharmaceutical firm founded in 1959, operates as a subsidiary of Torrent Investments Private Limited. Originally established as Trinity Laboratories before adopting its current name in 1971, the company is deeply involved in the research, development, production, and global commercialization of generic pharmaceutical products. Its market presence extends across India, the United States, Brazil, Germany, and other international regions. Torrent Pharma's diverse product line addresses numerous therapeutic categories, including cardiovascular, central nervous system, and gastrointestinal disorders, as well as women's health, diabetology, pain management, gynecology, oncology, and anti-infective treatments. Additionally, the company provides essential vitamins, minerals, and nutrient supplements, and offers contract manufacturing services to other entities.
www.torrentpharma.comNo one on the platform currently holds TORNTPHARM.BO.
No tracked institution reports a position in TORNTPHARM.BO as of their last filing.
No one on the platform has traded TORNTPHARM.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 11.6% | 15.0% | 13.4% | — | — | — |
| Rev. Growth % | 23.5% | 12.1% | ||||
| Profit Margin % | 15.5% | 14.1% | 13.3% | |||
| Free Cash Flow Margin % | 14.0% | 19.2% | 15.6% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $197.1B | +46.6% | $68.33 | $63.91–$73.57 | — | 24 |
| 2028 | $222.0B | +12.7% | $93.56 | $88.32–$97.90 | — | 18 |
| 2029 | $249.1B | +12.2% | $117.38 | $110.81–$122.82 | — | 11 |
| 2030 | $208.7B | -16.2% | $0.00 | $0.00–$0.00 | — | 11 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-30 | $14.95 | $15.40 | +3.0% |
| 2026-05-22 | $20.19 | $12.82 | -36.5% |
| 2026-02-13 | $18.20 | $19.00 | +4.4% |
| 2025-11-07 | $18.26 | $17.75 | -2.8% |
| 2025-07-28 | $17.11 | $16.35 | -4.4% |
| 2025-05-20 | $14.35 | $15.40 | +7.3% |
| 2025-01-24 | $15.08 | $14.90 | -1.2% |
| 2024-10-25 | $14.82 |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| TORNTPHARM.BOTorrent Pharmaceuticals Limited | $4850.00 | -2.51% | $1.85T | — |
| CIPLA.BOCipla Limited | $1361.00 | -0.29% | $1.11T | — |
| CIPLA.NSCipla Limited | $1351.00 | -1.10% | $1.09T | — |
| DRREDDY.BODr. Reddy's Laboratories Limited | $1149.75 | -0.97% | $966.0B | — |
| DRREDDY.NSDr. Reddy's Laboratories Limited |
| $13.37 |
| -9.8% |
| $1145.00 |
| -1.76% |
| $953.8B |
| — |
| LUPIN.BOLupin Limited | $2055.35 | -1.94% | $937.2B | — |
| LUPIN.NSLupin Limited | $2063.20 | -1.52% | $943.4B | — |
Source: Financial Modeling Prep · peers by sector/industry